SCHEMBL2724899

SCHEMBL2724899

COc1cc(F)c(-c2c3ccccc3c(-c3c(F)cc(OC)cc3F)c3c(F)ccc(F)c23)c(F)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.38
ROCK2 O75116 2/20 0.38
CDK2 P24941 2/20 0.38
MAOA P21397 2/20 0.38
CCNE2 O96020 1/20 0.38
CDK4 P11802 1/20 0.38
CCND1 P24385 1/20 0.38
CCNE1 P24864 1/20 0.38
CAMK2B Q13554 1/20 0.38
CAMK2G Q13555 1/20 0.38
CAMK2D Q13557 1/20 0.38
CAMK2A Q9UQM7 1/20 0.38
KDM1A O60341 1/20 0.38
MAOB P27338 1/20 0.38
CYP1A2 P05177 2/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1B1 Q16678 1/20 0.36
CA4 P22748 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
HDAC1 Q13547 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2724680 0.94 MAOA (0.35) TAAR1ROCK2CDK2MAOACCNE2
SCHEMBL2728177 0.92 ACHE (0.38) ROCK2CDK2MAOACCNE2CDK4
SCHEMBL2726374 0.92 MAOA (0.34) TAAR1ROCK2CDK2MAOACCNE2
SCHEMBL2725022 0.91 ACHE (0.43) MAOBL3MBTL1MAPTALDH1A1KDM4E
SCHEMBL2729052 0.89 L3MBTL1 (0.36) TAAR1ROCK2CDK2MAOACCNE2
SCHEMBL2724837 0.89 KDM4E (0.35) TAAR1ROCK2CDK2MAOACCNE2
SCHEMBL2939509 0.89 L3MBTL1 (0.41) ROCK2CDK2MAOACCNE2CDK4
SCHEMBL2712308 0.89 TAAR1 (0.42) TAAR1MAOAKDM1AMAOBCYP1A2
SCHEMBL2727335 0.88 ALDH1A1 (0.37) TAAR1ROCK2CDK2MAOACCNE2
SCHEMBL2710330 0.88 NFE2L2 (0.38) TAAR1CDK2MAOAKDM1AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
EP-2445987-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS Cyalume Technologies, Inc (US) 2012-05-02 EP disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
WO-2010151654-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECHNOLOGIES, INC. (US) 2010-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYP2F1, FLAD1, AFF1 TAAR1 1993/4885ROCK2 4178/4885CDK2 1367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.